2016
Sacks NC , Noone J, Cyr PL , Miller DJ, Chiarella MT, Louie AC. Hospitalizations for older patients with acute myeloid leukemia (AML): High costs and long stays, with and without chemotherapy. Academy Health Annual Research Meetings, Boston, MA, 2016.
Publication: Abstracts and Presentations
/ Topics: Cancer , Health Economics and Outcomes Research (HEOR)
Jensen IS , Wu C, Fan W, Lodise T, Nicolau, DP, DuFour S, Cyr PL , et al. 2016. Use of oritivancin in moderate-severe ABSSSI patients requiring IV antibiotics: US hospital budget impact analysis. J Manag Care Spec Pharm 22(6):752-64; doi: 10.18553/jmcp.2016.22.6.752 .
View Abstract
Publication: Manuscripts
/ Topics: Epidemiology , Health Economics and Outcomes Research (HEOR)
Jensen IS , Lodise TP, Fan W, Wu C, Cyr PL , Nicolau DP, DuFour S, et al. 2016. Use of oritavancin in acute bacterial skin and skin structure infection patients receiving intravenous antibiotics: A US hospital budget impact analysis. Clin Drug Investig. 2016 36(2):157-68; doi: 10.1007/s40261-015-0365-8 .
View Abstract
Publication: Manuscripts
/ Topics: Epidemiology , Health Economics and Outcomes Research (HEOR)
Cetin K, Callaghan F, Fryzek J, Bylsma L , Bezold C, Mehta B. Safety and efficacy/effectiveness of second-line treatments in patients with Immune Thrombocytopenia: A systematic review of the literature. Presented at the 21st Congress of the European Hematology Association, Copenhagen, Denmark, June 2016.